nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—thymus cancer—lung cancer	0.773	1	CtDrD
Octreotide—MPO—Cisplatin—lung cancer	0.045	1	CbGbCtD
Octreotide—Arthralgia—Docetaxel—lung cancer	3.97e-05	0.000339	CcSEcCtD
Octreotide—Myalgia—Docetaxel—lung cancer	3.97e-05	0.000339	CcSEcCtD
Octreotide—Nausea—Vinorelbine—lung cancer	3.96e-05	0.000339	CcSEcCtD
Octreotide—Gastrointestinal disorder—Etoposide—lung cancer	3.95e-05	0.000338	CcSEcCtD
Octreotide—Dyspepsia—Paclitaxel—lung cancer	3.95e-05	0.000338	CcSEcCtD
Octreotide—Body temperature increased—Cisplatin—lung cancer	3.95e-05	0.000338	CcSEcCtD
Octreotide—Asthenia—Irinotecan—lung cancer	3.95e-05	0.000338	CcSEcCtD
Octreotide—Fatigue—Etoposide—lung cancer	3.95e-05	0.000337	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	3.94e-05	0.000337	CcSEcCtD
Octreotide—Constipation—Etoposide—lung cancer	3.91e-05	0.000335	CcSEcCtD
Octreotide—Pain—Etoposide—lung cancer	3.91e-05	0.000335	CcSEcCtD
Octreotide—Dysuria—Doxorubicin—lung cancer	3.9e-05	0.000334	CcSEcCtD
Octreotide—Decreased appetite—Paclitaxel—lung cancer	3.9e-05	0.000334	CcSEcCtD
Octreotide—Dry mouth—Docetaxel—lung cancer	3.88e-05	0.000332	CcSEcCtD
Octreotide—Upper respiratory tract infection—Doxorubicin—lung cancer	3.88e-05	0.000332	CcSEcCtD
Octreotide—Gastrointestinal disorder—Paclitaxel—lung cancer	3.87e-05	0.000331	CcSEcCtD
Octreotide—Fatigue—Paclitaxel—lung cancer	3.87e-05	0.000331	CcSEcCtD
Octreotide—Hepatitis—Methotrexate—lung cancer	3.86e-05	0.00033	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—lung cancer	3.86e-05	0.00033	CcSEcCtD
Octreotide—Asthenia—Gemcitabine—lung cancer	3.84e-05	0.000329	CcSEcCtD
Octreotide—Pain—Paclitaxel—lung cancer	3.84e-05	0.000328	CcSEcCtD
Octreotide—Constipation—Paclitaxel—lung cancer	3.84e-05	0.000328	CcSEcCtD
Octreotide—Pharyngitis—Methotrexate—lung cancer	3.83e-05	0.000328	CcSEcCtD
Octreotide—Oedema—Docetaxel—lung cancer	3.8e-05	0.000325	CcSEcCtD
Octreotide—Anaphylactic shock—Docetaxel—lung cancer	3.8e-05	0.000325	CcSEcCtD
Octreotide—Weight increased—Doxorubicin—lung cancer	3.8e-05	0.000325	CcSEcCtD
Octreotide—Pruritus—Gemcitabine—lung cancer	3.79e-05	0.000324	CcSEcCtD
Octreotide—Infection—Docetaxel—lung cancer	3.78e-05	0.000323	CcSEcCtD
Octreotide—Weight decreased—Doxorubicin—lung cancer	3.78e-05	0.000323	CcSEcCtD
Octreotide—Feeling abnormal—Etoposide—lung cancer	3.77e-05	0.000323	CcSEcCtD
Octreotide—Hyperglycaemia—Doxorubicin—lung cancer	3.77e-05	0.000322	CcSEcCtD
Octreotide—Diarrhoea—Irinotecan—lung cancer	3.76e-05	0.000322	CcSEcCtD
Octreotide—Pneumonia—Doxorubicin—lung cancer	3.74e-05	0.00032	CcSEcCtD
Octreotide—Gastrointestinal pain—Etoposide—lung cancer	3.74e-05	0.00032	CcSEcCtD
Octreotide—Shock—Docetaxel—lung cancer	3.74e-05	0.00032	CcSEcCtD
Octreotide—Nervous system disorder—Docetaxel—lung cancer	3.73e-05	0.000319	CcSEcCtD
Octreotide—Thrombocytopenia—Docetaxel—lung cancer	3.72e-05	0.000318	CcSEcCtD
Octreotide—Drowsiness—Doxorubicin—lung cancer	3.72e-05	0.000318	CcSEcCtD
Octreotide—Visual impairment—Methotrexate—lung cancer	3.72e-05	0.000318	CcSEcCtD
Octreotide—Tachycardia—Docetaxel—lung cancer	3.71e-05	0.000317	CcSEcCtD
Octreotide—Feeling abnormal—Paclitaxel—lung cancer	3.7e-05	0.000316	CcSEcCtD
Octreotide—Skin disorder—Docetaxel—lung cancer	3.69e-05	0.000316	CcSEcCtD
Octreotide—Hypersensitivity—Cisplatin—lung cancer	3.68e-05	0.000315	CcSEcCtD
Octreotide—Gastrointestinal pain—Paclitaxel—lung cancer	3.67e-05	0.000314	CcSEcCtD
Octreotide—Diarrhoea—Gemcitabine—lung cancer	3.67e-05	0.000314	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—lung cancer	3.65e-05	0.000312	CcSEcCtD
Octreotide—Dizziness—Irinotecan—lung cancer	3.64e-05	0.000311	CcSEcCtD
Octreotide—Urticaria—Etoposide—lung cancer	3.64e-05	0.000311	CcSEcCtD
Octreotide—Jaundice—Doxorubicin—lung cancer	3.63e-05	0.00031	CcSEcCtD
Octreotide—Anorexia—Docetaxel—lung cancer	3.63e-05	0.00031	CcSEcCtD
Octreotide—Abdominal pain—Etoposide—lung cancer	3.62e-05	0.000309	CcSEcCtD
Octreotide—Body temperature increased—Etoposide—lung cancer	3.62e-05	0.000309	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—lung cancer	3.62e-05	0.000309	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—lung cancer	3.62e-05	0.000309	CcSEcCtD
Octreotide—Tinnitus—Methotrexate—lung cancer	3.6e-05	0.000308	CcSEcCtD
Octreotide—Asthenia—Cisplatin—lung cancer	3.58e-05	0.000307	CcSEcCtD
Octreotide—Cardiac disorder—Methotrexate—lung cancer	3.58e-05	0.000306	CcSEcCtD
Octreotide—Urticaria—Paclitaxel—lung cancer	3.56e-05	0.000305	CcSEcCtD
Octreotide—Haematuria—Doxorubicin—lung cancer	3.55e-05	0.000304	CcSEcCtD
Octreotide—Body temperature increased—Paclitaxel—lung cancer	3.55e-05	0.000303	CcSEcCtD
Octreotide—Abdominal pain—Paclitaxel—lung cancer	3.55e-05	0.000303	CcSEcCtD
Octreotide—Hepatobiliary disease—Doxorubicin—lung cancer	3.52e-05	0.000301	CcSEcCtD
Octreotide—Epistaxis—Doxorubicin—lung cancer	3.51e-05	0.0003	CcSEcCtD
Octreotide—Vomiting—Irinotecan—lung cancer	3.5e-05	0.000299	CcSEcCtD
Octreotide—Sinusitis—Doxorubicin—lung cancer	3.49e-05	0.000299	CcSEcCtD
Octreotide—Immune system disorder—Methotrexate—lung cancer	3.48e-05	0.000298	CcSEcCtD
Octreotide—Rash—Irinotecan—lung cancer	3.47e-05	0.000297	CcSEcCtD
Octreotide—Dermatitis—Irinotecan—lung cancer	3.47e-05	0.000296	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Docetaxel—lung cancer	3.46e-05	0.000296	CcSEcCtD
Octreotide—Headache—Irinotecan—lung cancer	3.45e-05	0.000295	CcSEcCtD
Octreotide—Insomnia—Docetaxel—lung cancer	3.44e-05	0.000294	CcSEcCtD
Octreotide—Diarrhoea—Cisplatin—lung cancer	3.42e-05	0.000292	CcSEcCtD
Octreotide—Paraesthesia—Docetaxel—lung cancer	3.41e-05	0.000292	CcSEcCtD
Octreotide—Alopecia—Methotrexate—lung cancer	3.41e-05	0.000292	CcSEcCtD
Octreotide—Vomiting—Gemcitabine—lung cancer	3.41e-05	0.000291	CcSEcCtD
Octreotide—Bradycardia—Doxorubicin—lung cancer	3.4e-05	0.000291	CcSEcCtD
Octreotide—Dyspnoea—Docetaxel—lung cancer	3.39e-05	0.00029	CcSEcCtD
Octreotide—Somnolence—Docetaxel—lung cancer	3.38e-05	0.000289	CcSEcCtD
Octreotide—Mental disorder—Methotrexate—lung cancer	3.38e-05	0.000289	CcSEcCtD
Octreotide—Rash—Gemcitabine—lung cancer	3.38e-05	0.000289	CcSEcCtD
Octreotide—Dermatitis—Gemcitabine—lung cancer	3.38e-05	0.000289	CcSEcCtD
Octreotide—Hypersensitivity—Etoposide—lung cancer	3.37e-05	0.000288	CcSEcCtD
Octreotide—Erythema—Methotrexate—lung cancer	3.36e-05	0.000287	CcSEcCtD
Octreotide—Malnutrition—Methotrexate—lung cancer	3.36e-05	0.000287	CcSEcCtD
Octreotide—Headache—Gemcitabine—lung cancer	3.36e-05	0.000287	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—lung cancer	3.35e-05	0.000286	CcSEcCtD
Octreotide—Dyspepsia—Docetaxel—lung cancer	3.35e-05	0.000286	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—lung cancer	3.34e-05	0.000286	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—lung cancer	3.32e-05	0.000284	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—lung cancer	3.32e-05	0.000284	CcSEcCtD
Octreotide—Decreased appetite—Docetaxel—lung cancer	3.31e-05	0.000283	CcSEcCtD
Octreotide—Hypersensitivity—Paclitaxel—lung cancer	3.31e-05	0.000283	CcSEcCtD
Octreotide—Oedema peripheral—Doxorubicin—lung cancer	3.29e-05	0.000282	CcSEcCtD
Octreotide—Gastrointestinal disorder—Docetaxel—lung cancer	3.28e-05	0.000281	CcSEcCtD
Octreotide—Asthenia—Etoposide—lung cancer	3.28e-05	0.000281	CcSEcCtD
Octreotide—Fatigue—Docetaxel—lung cancer	3.28e-05	0.00028	CcSEcCtD
Octreotide—Nausea—Irinotecan—lung cancer	3.27e-05	0.00028	CcSEcCtD
Octreotide—Constipation—Docetaxel—lung cancer	3.25e-05	0.000278	CcSEcCtD
Octreotide—Pain—Docetaxel—lung cancer	3.25e-05	0.000278	CcSEcCtD
Octreotide—Back pain—Methotrexate—lung cancer	3.25e-05	0.000278	CcSEcCtD
Octreotide—Pruritus—Etoposide—lung cancer	3.24e-05	0.000277	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—lung cancer	3.22e-05	0.000275	CcSEcCtD
Octreotide—Asthenia—Paclitaxel—lung cancer	3.22e-05	0.000275	CcSEcCtD
Octreotide—Nausea—Gemcitabine—lung cancer	3.18e-05	0.000272	CcSEcCtD
Octreotide—Vomiting—Cisplatin—lung cancer	3.18e-05	0.000272	CcSEcCtD
Octreotide—Pruritus—Paclitaxel—lung cancer	3.17e-05	0.000272	CcSEcCtD
Octreotide—Vision blurred—Methotrexate—lung cancer	3.17e-05	0.000271	CcSEcCtD
Octreotide—Rash—Cisplatin—lung cancer	3.15e-05	0.000269	CcSEcCtD
Octreotide—Dermatitis—Cisplatin—lung cancer	3.15e-05	0.000269	CcSEcCtD
Octreotide—Feeling abnormal—Docetaxel—lung cancer	3.13e-05	0.000268	CcSEcCtD
Octreotide—Diarrhoea—Etoposide—lung cancer	3.13e-05	0.000268	CcSEcCtD
Octreotide—Ill-defined disorder—Methotrexate—lung cancer	3.12e-05	0.000267	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—lung cancer	3.11e-05	0.000266	CcSEcCtD
Octreotide—Gastrointestinal pain—Docetaxel—lung cancer	3.11e-05	0.000266	CcSEcCtD
Octreotide—Anaemia—Methotrexate—lung cancer	3.1e-05	0.000266	CcSEcCtD
Octreotide—Flushing—Doxorubicin—lung cancer	3.1e-05	0.000265	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—lung cancer	3.1e-05	0.000265	CcSEcCtD
Octreotide—Diarrhoea—Paclitaxel—lung cancer	3.07e-05	0.000263	CcSEcCtD
Octreotide—Malaise—Methotrexate—lung cancer	3.03e-05	0.000259	CcSEcCtD
Octreotide—Dizziness—Etoposide—lung cancer	3.03e-05	0.000259	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—lung cancer	3.02e-05	0.000258	CcSEcCtD
Octreotide—Vertigo—Methotrexate—lung cancer	3.02e-05	0.000258	CcSEcCtD
Octreotide—Body temperature increased—Docetaxel—lung cancer	3.01e-05	0.000257	CcSEcCtD
Octreotide—Abdominal pain—Docetaxel—lung cancer	3.01e-05	0.000257	CcSEcCtD
Octreotide—Arrhythmia—Doxorubicin—lung cancer	2.98e-05	0.000255	CcSEcCtD
Octreotide—Dizziness—Paclitaxel—lung cancer	2.97e-05	0.000254	CcSEcCtD
Octreotide—Nausea—Cisplatin—lung cancer	2.97e-05	0.000254	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—lung cancer	2.95e-05	0.000253	CcSEcCtD
Octreotide—Cough—Methotrexate—lung cancer	2.93e-05	0.000251	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—lung cancer	2.93e-05	0.00025	CcSEcCtD
Octreotide—Convulsion—Methotrexate—lung cancer	2.91e-05	0.000249	CcSEcCtD
Octreotide—Vomiting—Etoposide—lung cancer	2.91e-05	0.000249	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—lung cancer	2.91e-05	0.000249	CcSEcCtD
Octreotide—Erythema—Doxorubicin—lung cancer	2.91e-05	0.000249	CcSEcCtD
Octreotide—Rash—Etoposide—lung cancer	2.89e-05	0.000247	CcSEcCtD
Octreotide—Dermatitis—Etoposide—lung cancer	2.88e-05	0.000247	CcSEcCtD
Octreotide—Headache—Etoposide—lung cancer	2.87e-05	0.000245	CcSEcCtD
Octreotide—Flatulence—Doxorubicin—lung cancer	2.87e-05	0.000245	CcSEcCtD
Octreotide—Arthralgia—Methotrexate—lung cancer	2.86e-05	0.000245	CcSEcCtD
Octreotide—Myalgia—Methotrexate—lung cancer	2.86e-05	0.000245	CcSEcCtD
Octreotide—Chest pain—Methotrexate—lung cancer	2.86e-05	0.000245	CcSEcCtD
Octreotide—Tension—Doxorubicin—lung cancer	2.85e-05	0.000244	CcSEcCtD
Octreotide—Vomiting—Paclitaxel—lung cancer	2.85e-05	0.000244	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.84e-05	0.000243	CcSEcCtD
Octreotide—Rash—Paclitaxel—lung cancer	2.83e-05	0.000242	CcSEcCtD
Octreotide—Dermatitis—Paclitaxel—lung cancer	2.83e-05	0.000242	CcSEcCtD
Octreotide—Discomfort—Methotrexate—lung cancer	2.83e-05	0.000242	CcSEcCtD
Octreotide—Nervousness—Doxorubicin—lung cancer	2.82e-05	0.000242	CcSEcCtD
Octreotide—Back pain—Doxorubicin—lung cancer	2.81e-05	0.000241	CcSEcCtD
Octreotide—Headache—Paclitaxel—lung cancer	2.81e-05	0.00024	CcSEcCtD
Octreotide—Hypersensitivity—Docetaxel—lung cancer	2.8e-05	0.00024	CcSEcCtD
Octreotide—Muscle spasms—Doxorubicin—lung cancer	2.8e-05	0.000239	CcSEcCtD
Octreotide—Anaphylactic shock—Methotrexate—lung cancer	2.74e-05	0.000234	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—lung cancer	2.74e-05	0.000234	CcSEcCtD
Octreotide—Asthenia—Docetaxel—lung cancer	2.73e-05	0.000233	CcSEcCtD
Octreotide—Infection—Methotrexate—lung cancer	2.72e-05	0.000233	CcSEcCtD
Octreotide—Nausea—Etoposide—lung cancer	2.72e-05	0.000232	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—lung cancer	2.7e-05	0.000231	CcSEcCtD
Octreotide—Pruritus—Docetaxel—lung cancer	2.69e-05	0.00023	CcSEcCtD
Octreotide—Nervous system disorder—Methotrexate—lung cancer	2.69e-05	0.00023	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—lung cancer	2.69e-05	0.00023	CcSEcCtD
Octreotide—Thrombocytopenia—Methotrexate—lung cancer	2.68e-05	0.00023	CcSEcCtD
Octreotide—Agitation—Doxorubicin—lung cancer	2.67e-05	0.000229	CcSEcCtD
Octreotide—Nausea—Paclitaxel—lung cancer	2.67e-05	0.000228	CcSEcCtD
Octreotide—Skin disorder—Methotrexate—lung cancer	2.66e-05	0.000228	CcSEcCtD
Octreotide—Hyperhidrosis—Methotrexate—lung cancer	2.65e-05	0.000227	CcSEcCtD
Octreotide—Malaise—Doxorubicin—lung cancer	2.62e-05	0.000224	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—lung cancer	2.61e-05	0.000223	CcSEcCtD
Octreotide—Anorexia—Methotrexate—lung cancer	2.61e-05	0.000223	CcSEcCtD
Octreotide—Syncope—Doxorubicin—lung cancer	2.61e-05	0.000223	CcSEcCtD
Octreotide—Diarrhoea—Docetaxel—lung cancer	2.6e-05	0.000223	CcSEcCtD
Octreotide—Palpitations—Doxorubicin—lung cancer	2.57e-05	0.00022	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—lung cancer	2.56e-05	0.000219	CcSEcCtD
Octreotide—Cough—Doxorubicin—lung cancer	2.54e-05	0.000217	CcSEcCtD
Octreotide—Convulsion—Doxorubicin—lung cancer	2.52e-05	0.000216	CcSEcCtD
Octreotide—Dizziness—Docetaxel—lung cancer	2.51e-05	0.000215	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—lung cancer	2.51e-05	0.000215	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methotrexate—lung cancer	2.5e-05	0.000214	CcSEcCtD
Octreotide—Insomnia—Methotrexate—lung cancer	2.48e-05	0.000212	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—lung cancer	2.48e-05	0.000212	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—lung cancer	2.48e-05	0.000212	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—lung cancer	2.48e-05	0.000212	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—lung cancer	2.47e-05	0.000211	CcSEcCtD
Octreotide—Paraesthesia—Methotrexate—lung cancer	2.46e-05	0.000211	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.46e-05	0.00021	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—lung cancer	2.45e-05	0.000209	CcSEcCtD
Octreotide—Dyspnoea—Methotrexate—lung cancer	2.44e-05	0.000209	CcSEcCtD
Octreotide—Somnolence—Methotrexate—lung cancer	2.44e-05	0.000208	CcSEcCtD
Octreotide—Dry mouth—Doxorubicin—lung cancer	2.42e-05	0.000207	CcSEcCtD
Octreotide—Vomiting—Docetaxel—lung cancer	2.42e-05	0.000207	CcSEcCtD
Octreotide—Dyspepsia—Methotrexate—lung cancer	2.41e-05	0.000206	CcSEcCtD
Octreotide—Rash—Docetaxel—lung cancer	2.4e-05	0.000205	CcSEcCtD
Octreotide—Dermatitis—Docetaxel—lung cancer	2.4e-05	0.000205	CcSEcCtD
Octreotide—Decreased appetite—Methotrexate—lung cancer	2.38e-05	0.000204	CcSEcCtD
Octreotide—Headache—Docetaxel—lung cancer	2.38e-05	0.000204	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—lung cancer	2.37e-05	0.000203	CcSEcCtD
Octreotide—Oedema—Doxorubicin—lung cancer	2.37e-05	0.000203	CcSEcCtD
Octreotide—Gastrointestinal disorder—Methotrexate—lung cancer	2.37e-05	0.000202	CcSEcCtD
Octreotide—Fatigue—Methotrexate—lung cancer	2.36e-05	0.000202	CcSEcCtD
Octreotide—Infection—Doxorubicin—lung cancer	2.36e-05	0.000202	CcSEcCtD
Octreotide—Pain—Methotrexate—lung cancer	2.34e-05	0.0002	CcSEcCtD
Octreotide—Shock—Doxorubicin—lung cancer	2.34e-05	0.0002	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—lung cancer	2.33e-05	0.000199	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—lung cancer	2.32e-05	0.000199	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—lung cancer	2.32e-05	0.000198	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—lung cancer	2.31e-05	0.000197	CcSEcCtD
Octreotide—Hyperhidrosis—Doxorubicin—lung cancer	2.29e-05	0.000196	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—lung cancer	2.26e-05	0.000194	CcSEcCtD
Octreotide—Nausea—Docetaxel—lung cancer	2.26e-05	0.000193	CcSEcCtD
Octreotide—Feeling abnormal—Methotrexate—lung cancer	2.26e-05	0.000193	CcSEcCtD
Octreotide—Gastrointestinal pain—Methotrexate—lung cancer	2.24e-05	0.000192	CcSEcCtD
Octreotide—Urticaria—Methotrexate—lung cancer	2.18e-05	0.000186	CcSEcCtD
Octreotide—Abdominal pain—Methotrexate—lung cancer	2.17e-05	0.000185	CcSEcCtD
Octreotide—Body temperature increased—Methotrexate—lung cancer	2.17e-05	0.000185	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.16e-05	0.000185	CcSEcCtD
Octreotide—Insomnia—Doxorubicin—lung cancer	2.15e-05	0.000184	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—IL2—lung cancer	2.14e-05	0.000327	CbGpPWpGaD
Octreotide—Paraesthesia—Doxorubicin—lung cancer	2.13e-05	0.000182	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—FGFR1—lung cancer	2.12e-05	0.000324	CbGpPWpGaD
Octreotide—Dyspnoea—Doxorubicin—lung cancer	2.12e-05	0.000181	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—PIK3CB—lung cancer	2.11e-05	0.000323	CbGpPWpGaD
Octreotide—Somnolence—Doxorubicin—lung cancer	2.11e-05	0.00018	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—APOA1—lung cancer	2.1e-05	0.000321	CbGpPWpGaD
Octreotide—Dyspepsia—Doxorubicin—lung cancer	2.09e-05	0.000179	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HIF1A—lung cancer	2.08e-05	0.000319	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KDR—lung cancer	2.08e-05	0.000318	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1R—lung cancer	2.07e-05	0.000317	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—lung cancer	2.06e-05	0.000316	CbGpPWpGaD
Octreotide—Decreased appetite—Doxorubicin—lung cancer	2.06e-05	0.000176	CcSEcCtD
Octreotide—Gastrointestinal disorder—Doxorubicin—lung cancer	2.05e-05	0.000175	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—lung cancer	2.05e-05	0.000175	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HES1—lung cancer	2.04e-05	0.000312	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—lung cancer	2.03e-05	0.000311	CbGpPWpGaD
Octreotide—Pain—Doxorubicin—lung cancer	2.03e-05	0.000174	CcSEcCtD
Octreotide—Constipation—Doxorubicin—lung cancer	2.03e-05	0.000174	CcSEcCtD
Octreotide—Hypersensitivity—Methotrexate—lung cancer	2.02e-05	0.000173	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—ERBB3—lung cancer	2.02e-05	0.000309	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOA1—lung cancer	2.01e-05	0.000308	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—lung cancer	2e-05	0.000306	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RAF1—lung cancer	2e-05	0.000306	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—lung cancer	1.99e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MDM2—lung cancer	1.99e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAF1—lung cancer	1.98e-05	0.000304	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—lung cancer	1.97e-05	0.000302	CbGpPWpGaD
Octreotide—Asthenia—Methotrexate—lung cancer	1.97e-05	0.000168	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—ERBB2—lung cancer	1.96e-05	0.0003	CbGpPWpGaD
Octreotide—Feeling abnormal—Doxorubicin—lung cancer	1.96e-05	0.000167	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—PIK3CB—lung cancer	1.95e-05	0.000298	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Doxorubicin—lung cancer	1.94e-05	0.000166	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—IL2—lung cancer	1.94e-05	0.000297	CbGpPWpGaD
Octreotide—Pruritus—Methotrexate—lung cancer	1.94e-05	0.000166	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MTOR—lung cancer	1.94e-05	0.000296	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	0.000296	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—lung cancer	1.93e-05	0.000296	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—lung cancer	1.92e-05	0.000293	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—lung cancer	1.92e-05	0.000293	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KIT—lung cancer	1.92e-05	0.000293	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—NRAS—lung cancer	1.92e-05	0.000293	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGF—lung cancer	1.89e-05	0.00029	CbGpPWpGaD
Octreotide—Urticaria—Doxorubicin—lung cancer	1.89e-05	0.000161	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—FGFR1—lung cancer	1.88e-05	0.000287	CbGpPWpGaD
Octreotide—Abdominal pain—Doxorubicin—lung cancer	1.88e-05	0.00016	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—lung cancer	1.88e-05	0.00016	CcSEcCtD
Octreotide—Diarrhoea—Methotrexate—lung cancer	1.88e-05	0.00016	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—lung cancer	1.87e-05	0.000287	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB3—lung cancer	1.86e-05	0.000285	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—lung cancer	1.86e-05	0.000285	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRAS—lung cancer	1.85e-05	0.000283	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—lung cancer	1.85e-05	0.000283	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—lung cancer	1.84e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KIT—lung cancer	1.84e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—lung cancer	1.84e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—NRAS—lung cancer	1.84e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK3—lung cancer	1.83e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—POMC—lung cancer	1.82e-05	0.000279	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGF—lung cancer	1.82e-05	0.000278	CbGpPWpGaD
Octreotide—Dizziness—Methotrexate—lung cancer	1.81e-05	0.000155	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—BRAF—lung cancer	1.8e-05	0.000275	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	0.000275	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—lung cancer	1.79e-05	0.000274	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—lung cancer	1.78e-05	0.000273	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOA1—lung cancer	1.78e-05	0.000273	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—lung cancer	1.78e-05	0.000273	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—lung cancer	1.78e-05	0.000272	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6R—lung cancer	1.78e-05	0.000272	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CREBBP—lung cancer	1.78e-05	0.000272	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—lung cancer	1.77e-05	0.000271	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—lung cancer	1.77e-05	0.000271	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK3—lung cancer	1.76e-05	0.000269	CbGpPWpGaD
Octreotide—Hypersensitivity—Doxorubicin—lung cancer	1.75e-05	0.00015	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—POMC—lung cancer	1.75e-05	0.000267	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—lung cancer	1.75e-05	0.000267	CbGpPWpGaD
Octreotide—Vomiting—Methotrexate—lung cancer	1.74e-05	0.000149	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CCND1—lung cancer	1.73e-05	0.000265	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGFR1—lung cancer	1.73e-05	0.000265	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JUN—lung cancer	1.73e-05	0.000265	CbGpPWpGaD
Octreotide—Rash—Methotrexate—lung cancer	1.73e-05	0.000148	CcSEcCtD
Octreotide—Dermatitis—Methotrexate—lung cancer	1.73e-05	0.000148	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—BRAF—lung cancer	1.73e-05	0.000264	CbGpPWpGaD
Octreotide—Headache—Methotrexate—lung cancer	1.72e-05	0.000147	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HIF1A—lung cancer	1.71e-05	0.000261	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6R—lung cancer	1.71e-05	0.000261	CbGpPWpGaD
Octreotide—Asthenia—Doxorubicin—lung cancer	1.7e-05	0.000146	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CREBBP—lung cancer	1.7e-05	0.000261	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAP2K1—lung cancer	1.7e-05	0.000259	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—lung cancer	1.68e-05	0.000258	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—lung cancer	1.68e-05	0.000258	CbGpPWpGaD
Octreotide—Pruritus—Doxorubicin—lung cancer	1.68e-05	0.000144	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000257	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTEN—lung cancer	1.67e-05	0.000256	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—lung cancer	1.67e-05	0.000256	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—lung cancer	1.67e-05	0.000255	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—lung cancer	1.65e-05	0.000252	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOA1—lung cancer	1.65e-05	0.000252	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—lung cancer	1.63e-05	0.00025	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—lung cancer	1.63e-05	0.00025	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—lung cancer	1.63e-05	0.000249	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KIT—lung cancer	1.63e-05	0.000249	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—lung cancer	1.63e-05	0.000249	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NRAS—lung cancer	1.63e-05	0.000249	CbGpPWpGaD
Octreotide—Nausea—Methotrexate—lung cancer	1.63e-05	0.000139	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—MAP2K1—lung cancer	1.63e-05	0.000249	CbGpPWpGaD
Octreotide—Diarrhoea—Doxorubicin—lung cancer	1.62e-05	0.000139	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—lung cancer	1.61e-05	0.000247	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGF—lung cancer	1.61e-05	0.000246	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—lung cancer	1.6e-05	0.000245	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EP300—lung cancer	1.6e-05	0.000244	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—lung cancer	1.58e-05	0.000242	CbGpPWpGaD
Octreotide—Dizziness—Doxorubicin—lung cancer	1.57e-05	0.000134	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—MAPK3—lung cancer	1.56e-05	0.000239	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SRC—lung cancer	1.55e-05	0.000237	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—POMC—lung cancer	1.55e-05	0.000237	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BRAF—lung cancer	1.53e-05	0.000234	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—lung cancer	1.51e-05	0.000232	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6R—lung cancer	1.51e-05	0.000231	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—lung cancer	1.51e-05	0.000231	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CREBBP—lung cancer	1.51e-05	0.000231	CbGpPWpGaD
Octreotide—Vomiting—Doxorubicin—lung cancer	1.51e-05	0.000129	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—MDM2—lung cancer	1.51e-05	0.000231	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAF1—lung cancer	1.5e-05	0.00023	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—lung cancer	1.5e-05	0.00023	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—lung cancer	1.5e-05	0.00023	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KIT—lung cancer	1.5e-05	0.00023	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NRAS—lung cancer	1.5e-05	0.00023	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.000229	CbGpPWpGaD
Octreotide—Rash—Doxorubicin—lung cancer	1.5e-05	0.000128	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—lung cancer	1.5e-05	0.000128	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NRAS—lung cancer	1.49e-05	0.000228	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—lung cancer	1.49e-05	0.000228	CbGpPWpGaD
Octreotide—Headache—Doxorubicin—lung cancer	1.49e-05	0.000127	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—EGF—lung cancer	1.49e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—lung cancer	1.48e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—lung cancer	1.47e-05	0.000225	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—lung cancer	1.47e-05	0.000225	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—lung cancer	1.45e-05	0.000222	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MDM2—lung cancer	1.45e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAF1—lung cancer	1.44e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAP2K1—lung cancer	1.44e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK3—lung cancer	1.44e-05	0.00022	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—lung cancer	1.43e-05	0.000219	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—POMC—lung cancer	1.43e-05	0.000219	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK3—lung cancer	1.43e-05	0.000219	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB2—lung cancer	1.43e-05	0.000218	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—lung cancer	1.42e-05	0.000217	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—lung cancer	1.41e-05	0.000216	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—lung cancer	1.41e-05	0.000216	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—lung cancer	1.41e-05	0.000121	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—MTOR—lung cancer	1.41e-05	0.000215	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—lung cancer	1.41e-05	0.000215	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—lung cancer	1.4e-05	0.000214	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—lung cancer	1.4e-05	0.000214	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6R—lung cancer	1.4e-05	0.000214	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CREBBP—lung cancer	1.39e-05	0.000213	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—lung cancer	1.39e-05	0.000213	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—lung cancer	1.37e-05	0.00021	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—lung cancer	1.36e-05	0.000208	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—lung cancer	1.36e-05	0.000208	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—lung cancer	1.35e-05	0.000207	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—lung cancer	1.35e-05	0.000207	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—lung cancer	1.35e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—lung cancer	1.34e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—lung cancer	1.34e-05	0.000205	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAP2K1—lung cancer	1.33e-05	0.000204	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—lung cancer	1.32e-05	0.000202	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—lung cancer	1.31e-05	0.000201	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUN—lung cancer	1.31e-05	0.000201	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—lung cancer	1.31e-05	0.0002	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—lung cancer	1.31e-05	0.0002	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—lung cancer	1.29e-05	0.000198	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—lung cancer	1.29e-05	0.000198	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—lung cancer	1.29e-05	0.000198	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—lung cancer	1.29e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—lung cancer	1.29e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—lung cancer	1.29e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MDM2—lung cancer	1.28e-05	0.000196	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAF1—lung cancer	1.28e-05	0.000196	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—lung cancer	1.28e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1A—lung cancer	1.27e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—lung cancer	1.27e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB2—lung cancer	1.26e-05	0.000193	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—lung cancer	1.26e-05	0.000193	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUN—lung cancer	1.26e-05	0.000192	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—lung cancer	1.25e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—lung cancer	1.25e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—lung cancer	1.24e-05	0.000189	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—lung cancer	1.22e-05	0.000187	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1A—lung cancer	1.22e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—lung cancer	1.22e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EP300—lung cancer	1.21e-05	0.000185	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—lung cancer	1.2e-05	0.000183	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—lung cancer	1.19e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—lung cancer	1.19e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—lung cancer	1.19e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MDM2—lung cancer	1.18e-05	0.000181	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	0.000181	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAF1—lung cancer	1.18e-05	0.00018	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SRC—lung cancer	1.18e-05	0.00018	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB2—lung cancer	1.17e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EP300—lung cancer	1.16e-05	0.000177	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—lung cancer	1.16e-05	0.000177	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—lung cancer	1.15e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—lung cancer	1.15e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—lung cancer	1.15e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—lung cancer	1.14e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—lung cancer	1.14e-05	0.000174	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—lung cancer	1.13e-05	0.000174	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—lung cancer	1.13e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SRC—lung cancer	1.13e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—lung cancer	1.12e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JUN—lung cancer	1.12e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—lung cancer	1.11e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—lung cancer	1.1e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—lung cancer	1.1e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—lung cancer	1.09e-05	0.000167	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—lung cancer	1.09e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—lung cancer	1.08e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—lung cancer	1.08e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK3—lung cancer	1.08e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1A—lung cancer	1.08e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—lung cancer	1.08e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—lung cancer	1.07e-05	0.000164	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—lung cancer	1.06e-05	0.000162	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—lung cancer	1.06e-05	0.000162	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—lung cancer	1.05e-05	0.000161	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—lung cancer	1.05e-05	0.000161	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—lung cancer	1.05e-05	0.000161	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—lung cancer	1.05e-05	0.00016	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK3—lung cancer	1.04e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—lung cancer	1.03e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—lung cancer	1.03e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUN—lung cancer	1.03e-05	0.000157	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EP300—lung cancer	1.03e-05	0.000157	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—lung cancer	1.01e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—lung cancer	1e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SRC—lung cancer	1e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1A—lung cancer	9.98e-06	0.000153	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—lung cancer	9.95e-06	0.000152	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—lung cancer	9.88e-06	0.000151	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—lung cancer	9.74e-06	0.000149	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—lung cancer	9.74e-06	0.000149	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—lung cancer	9.71e-06	0.000149	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—lung cancer	9.65e-06	0.000148	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—lung cancer	9.65e-06	0.000148	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—lung cancer	9.62e-06	0.000147	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EP300—lung cancer	9.49e-06	0.000145	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—lung cancer	9.34e-06	0.000143	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SRC—lung cancer	9.23e-06	0.000141	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK3—lung cancer	9.22e-06	0.000141	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—lung cancer	8.99e-06	0.000138	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—lung cancer	8.96e-06	0.000137	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—lung cancer	8.95e-06	0.000137	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—lung cancer	8.9e-06	0.000136	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NRAS—lung cancer	8.88e-06	0.000136	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—lung cancer	8.77e-06	0.000134	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—lung cancer	8.66e-06	0.000132	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—lung cancer	8.58e-06	0.000131	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK3—lung cancer	8.5e-06	0.00013	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—lung cancer	8.3e-06	0.000127	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—lung cancer	8.28e-06	0.000127	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—lung cancer	8.28e-06	0.000127	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—lung cancer	8.27e-06	0.000127	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—lung cancer	8.09e-06	0.000124	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—lung cancer	7.94e-06	0.000121	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—lung cancer	7.92e-06	0.000121	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—lung cancer	7.64e-06	0.000117	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—lung cancer	7.61e-06	0.000116	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—lung cancer	7.6e-06	0.000116	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—lung cancer	7.36e-06	0.000113	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—lung cancer	7.31e-06	0.000112	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—lung cancer	7.04e-06	0.000108	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—lung cancer	7.02e-06	0.000107	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—lung cancer	7.01e-06	0.000107	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—lung cancer	6.79e-06	0.000104	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—lung cancer	6.74e-06	0.000103	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—lung cancer	6.5e-06	9.94e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—lung cancer	6.22e-06	9.51e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—lung cancer	6.22e-06	9.51e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—lung cancer	5.74e-06	8.78e-05	CbGpPWpGaD
